Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

298
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
298
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

379
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
379
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

424
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
424
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

854
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
854
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.3K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

323
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
323

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.

Aging cell·2026
Same author

RxnBench: A Multimodal Benchmark for Evaluating Large Language Models on Chemical Reaction Understanding from the Scientific Literature.

Journal of chemical information and modeling·2026
Same author

Identification and Evaluation of Conserved Subunit Vaccine Candidates Conferring Cross-Serotype Protection Against <i>Streptococcus suis</i> Serotypes 2, 7, 8, and 9.

Transboundary and emerging diseases·2026
Same author

RIVER delivers multimodal gene-directed regulatory interactions across diverse biological contexts with broad application potentials.

Science China. Life sciences·2026
Same author

NMR-Solver: automated structure elucidation via large-scale spectral matching and physics-guided fragment optimization.

Nature communications·2026
Same author

A dual-functional nanoplatform based on pH-driven self-assembly of pea protein isolate-folic acid conjugate for targeted and stabilized delivery of curcumin.

Food research international (Ottawa, Ont.)·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
Same journal

Structural and Thermodynamic Discrimination between Agonists and Antagonists of Retinoic Acid Receptor γ and the Vitamin D Receptor.

Journal of chemical information and modeling·2026
Same journal

PACEff Builder: An Efficient Platform for Constructing PACE Hybrid-Resolution Models for Molecular Dynamics Simulations of Aqueous Protein, Peptide Assembly, and Membrane Protein Systems.

Journal of chemical information and modeling·2026
Same journal

TransKla: A Local-Global Cross-Attention Based Transformer Approach for Prediction of Lysine Lactylation Sites.

Journal of chemical information and modeling·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Feb 26, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K

Hacia la farmacocinética generalizable impulsada por datos con EDO interpretables

Yaning Cui1, Xiaohong Ji1, Wentao Guo1,2

  • 1DP Technology, Beijing 100089, China.

Journal of chemical information and modeling
|February 25, 2026
PubMed
Resumen
Este resumen es generado por máquina.

Uni-PK, un marco neuronal novedoso, modela con precisión los perfiles de concentración de fármacos en el tiempo integrando datos moleculares y factores individuales. Este enfoque mejora las predicciones farmacocinéticas para la medicina personalizada, reduciendo las pruebas en animales.

Palabras clave:
farmacocinéticamodelado de fármacosaprendizaje profundoecuaciones diferenciales ordinarias neuronalesmedicina de precisión

Más Videos Relacionados

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

Videos de Experimentos Relacionados

Last Updated: Feb 26, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

Área de la Ciencia:

  • Farmacocinética y Biología Computacional
  • Desarrollo de Fármacos y Medicina de Precisión
  • Inteligencia Artificial en la Atención Médica

Sus antecedentes:

  • El modelado preciso del perfil de concentración-tiempo (C-t) de los fármacos es crucial para el desarrollo de fármacos y la dosificación personalizada.
  • Los modelos farmacocinéticos (PK) tradicionales enfrentan limitaciones en escalabilidad y adaptabilidad debido a suposiciones rígidas y parametrización extensa.
  • Existe la necesidad de enfoques de modelado avanzados que puedan manejar de manera efectiva diversos compuestos y poblaciones de pacientes.

Objetivo del estudio:

  • Introducir Uni-PK, un marco neuronal unificado para el modelado farmacocinético de extremo a extremo.
  • Desarrollar una solución escalable e interpretable para predecir la dinámica de la concentración de fármacos.
  • Permitir aplicaciones preclínicas y clínicas personalizadas incorporando la variabilidad interindividual.

Principales métodos:

  • Se desarrolló Uni-PK combinando representaciones moleculares con ecuaciones diferenciales ordinarias neuronales (NODEs) dentro de una estructura PK.
  • Se empleó un codificador de contexto flexible para integrar covariables auxiliares (por ejemplo, especie, régimen de dosificación) para el modelado personalizado.
  • Se permitió el modelado dinámico directo de trayectorias de concentraciones de fármacos a partir de entradas moleculares e individuales, facilitando el aprendizaje en condiciones de datos escasos.

Principales resultados:

  • Uni-PK demostró un rendimiento sólido en conjuntos de datos de ratas y humanos en diversas vías de administración y estados fisiológicos.
  • El marco mostró consistencia con los principios farmacocinéticos establecidos, validando su base mecanicista.
  • Logró capacidades de aprendizaje de extremo a extremo, incluso en condiciones de datos escasos y ruidosos, superando a los métodos tradicionales.

Conclusiones:

  • Uni-PK ofrece una solución escalable, interpretable y que evita el uso de animales para el modelado farmacocinético de próxima generación.
  • La integración de la estructura química y la información específica del individuo avanza las terapias de precisión.
  • Este marco neuronal unificado tiene el potencial de impactar significativamente el desarrollo de fármacos y las estrategias de dosificación individualizadas.